A higher yielding synthesis of the clinical prodrug ZD2767P using di-protected 4-[N,N-bis(2-hydroxyethyl)amino]phenyl chloroformate

A novel synthesis is described of the clinical trial prodrug ZD2767P that improves the overall yield from 13% to 45%.